Questions in cardiac resynchronization therapy: metabolic implications
- PMID: 16875992
- DOI: 10.1016/j.jacc.2006.05.001
Questions in cardiac resynchronization therapy: metabolic implications
Comment on
-
Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questions.J Am Coll Cardiol. 2005 Dec 20;46(12):2168-82. doi: 10.1016/j.jacc.2005.09.020. J Am Coll Cardiol. 2005. PMID: 16360043 Review.
Similar articles
-
[Cardiac resynchronization therapy: when the pacing site really matters].Rev Esp Cardiol. 2007 Feb;60(2):97-100. Rev Esp Cardiol. 2007. PMID: 17338873 Spanish. No abstract available.
-
Cost effectiveness of cardiac resynchronization therapy.J Am Coll Cardiol. 2005 Dec 20;46(12):2322-4. doi: 10.1016/j.jacc.2005.09.003. J Am Coll Cardiol. 2005. PMID: 16360065 No abstract available.
-
Role of septal to posterior wall motion delay in cardiac resynchronization therapy.J Am Coll Cardiol. 2006 Aug 1;48(3):596-7. doi: 10.1016/j.jacc.2006.05.017. Epub 2006 Jul 12. J Am Coll Cardiol. 2006. PMID: 16876000 No abstract available.
-
When hearts fail so does skeletal muscle: breaking a vicious cycle.Circ Res. 2006 Jun 23;98(12):1456-8. doi: 10.1161/01.RES.0000231259.29646.74. Circ Res. 2006. PMID: 16794192 Review. No abstract available.
-
Sex-based differences in cardiac resynchronization therapy and implantable cardioverter defibrillator therapies: effectiveness and use.Cardiol Rev. 2006 Nov-Dec;14(6):292-8. doi: 10.1097/01.crd.0000244462.33052.72. Cardiol Rev. 2006. PMID: 17053376 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical